Connected Drug Delivery Devices Global Market Report 2025

Description

Connected drug delivery devices are advanced pharmaceutical tools that employ digital technology to monitor, regulate, and oversee the dispensing of medications, thereby improving adherence and patient outcomes. These devices are capable of internet connectivity, enabling data exchange between patients and healthcare providers to monitor medication usage, adjust dosages, and enhance treatment strategies.

The primary categories of connected drug delivery devices encompass standalone components, software, and integrated devices. Standalone components and software denote software or hardware capable of functioning independently or separately from a medical device that generates or utilizes it. They leverage various technologies such as Bluetooth, near-field communication (NFC), and others. These devices cater to a range of routes of administration including parenteral and inhalational methods, and find applications in conditions like asthma, chronic obstructive pulmonary disease, diabetes management, among others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the pharmaceutical sector. Companies are grappling with higher costs on imported active pharmaceutical ingredients (APIs), glass vials, and laboratory equipment-many of which have limited alternative sources. Generic drug manufacturers, already operating with minimal profit margins, are particularly affected, with some scaling back production of low-margin medications. Biotech firms are also experiencing delays in clinical trials due to shortages of specialized reagents linked to tariffs. In response, the industry is shifting API production to regions like India and Europe, building up inventory reserves, and advocating for tariff exemptions on essential medicines.

The connected drug delivery devices market research report is one of a series of new reports from The Business Research Company that provides connected drug delivery devices market statistics, including connected drug delivery devices industry global market size, regional shares, competitors with a connected drug delivery devices market share, detailed connected drug delivery devices market segments, market trends and opportunities, and any further data you may need to thrive in the connected drug delivery devices industry. This connected drug delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The connected drug delivery devices market size has grown exponentially in recent years. It will grow from $7.48 billion in 2024 to $9.27 billion in 2025 at a compound annual growth rate (CAGR) of 23.9%. The growth in the historic period can be attributed to increased awareness of connected devices, increased importance of remote monitoring for medication adherence, increased patient engagement, widespread consumer adoption, the rapidly increasing cost of medical management.

The connected drug delivery devices market size is expected to see exponential growth in the next few years. It will grow to $21.81 billion in 2029 at a compound annual growth rate (CAGR) of 23.9%. The growth in the forecast period can be attributed to increasing prevalence of chronic diseases, rising patient awareness about adherence to prescribed therapies, rapidly moving healthcare it infrastructure, increasing emphasis on preventive care, widespread adoption of connected devices in laboratories and hospitals for maintaining electronic health records (EHR). Major trends in the forecast period include increasing R&D activities, surge in technological innovation and the increasing connectivity of devices, soaring adoption of machine learning and artificial intelligence, rising implementation of telehealth platform integrated with AR/VR technologies, increasing adoption of electronic technology in healthcare devices.

The forecast of 23.9% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may pose a significant challenge for chronic disease management by increasing costs of smart insulin pens and inhalers sourced from Sweden and Finland, potentially reducing treatment adherence monitoring and raising digital health technology costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growth of the connected drug delivery device market is anticipated to be propelled by the increasing significance of remote patient monitoring (RPM). Remote patient monitoring is a healthcare delivery method utilizing technology to monitor patient health and medical data from a distance. Connected drug delivery devices play a crucial role in enhancing RPM by enabling precise tracking of medication usage and adherence, facilitating timely interventions, and offering personalized care management. For example, a survey conducted by Vivalink Inc., a US-based digital health solutions provider, in August 2023, revealed a significant increase of 305% in clinicians utilizing RPM on patients, rising from 20% in 2021 to 81% presently, with 84% of these users planning to expand their RPM usage in 2024. Consequently, the growing importance of remote patient monitoring is propelling the growth of the connected drug delivery device market.

Major players in the connected drug delivery devices market are concentrating on developing innovative technologies, such as digital respiratory health solutions, to enhance their market profitability. Digital respiratory health solutions for connected drug delivery devices encompass technology-enabled devices facilitating medication delivery to the respiratory system while monitoring usage and health data to improve patient outcomes. For instance, in February 2022, AptarGroup Inc., a US-based manufacturer of dispensing packaging and drug delivery devices, introduced HeroTracker Sense. This innovative digital tool transforms traditional metered-dose inhalers into smart, connected devices, enhancing medication adherence and management for individuals with chronic respiratory conditions like asthma and COPD. It incorporates features such as sensors for analytics and insights, supporting patient adherence monitoring via the BreatheSmart app, thereby aiding in the effective management of respiratory diseases.

In May 2022, Halozyme Therapeutics Inc., a US-based biopharmaceutical company, acquired Antares Pharma Inc. for an undisclosed sum. This acquisition is expected to bolster Halozyme's strategy, solidify its position as a top drug delivery firm, and expand its coverage of specialized products with its best-in-class auto-injector technology and specialty commercial business. Antares Pharma Inc. is a US-based specialty pharmaceutical company operating in the connected drug delivery sector.

Major players in the connected drug delivery devices market are Pfizer Inc., Johnson & Johnson, Bayer AG, AstraZeneca PLC, Abbott Laboratories, Novartis AG, Medtronic PLC, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Merck Group, Becton Dickinson and Company, GlaxoSmithKline PLC, Phillips-Medisize Corporation, AptarGroup Inc., Dexcom Inc., West Pharmaceutical Services Inc., Insulet Corporation, OPKO Health Inc., Tandem Diabetes Care Inc., Ypsomed AG, Meridian Medical Technologies LLC, Propeller Health, and Findair Sp. z.o.o.

North America was the largest region in the connected drug delivery market in 2024. The regions covered in connected drug delivery device report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the connected drug delivery device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The connected drug delivery device market consists of revenues earned by entities by providing services such as medication reminders and alerts, dose tracking, data sharing, adjustable dosing, and integration with health records. The market value includes the value of related goods sold by the service provider or included within the service offering. The connected drug delivery device market also includes sales of smart inhalers, connected insulin pumps, smart pill dispensers, wearable drug delivery devices, and digital pills that are used in providing services. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Connected Drug Delivery Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on connected drug delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for connected drug delivery devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The connected drug delivery devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Standalone Components And Software; Integrated Devices
2) By Technology: Bluetooth; Near-Field Communication (NFC); Other Technologies
3) By Administration: Parenteral; Inhalational
4) By Application: Asthma; Chronic Obstructive Pulmonary Disease; Diabetes Management; Other Applications
Subsegments:
1) By Standalone Components And Software: Mobile Applications; Connectivity Modules; Data Analytics Software
2) By Integrated Devices: Smart Inhalers; Smart Auto-injectors; Connected Syringes; Wearable Drug Delivery Devices
Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Bayer AG; AstraZeneca PLC; Abbott Laboratories; Novartis AG; Medtronic PLC; Eli Lilly and Company; Amgen Inc.; Boehringer Ingelheim International GmbH; Novo Nordisk A/S; Merck Group; Becton Dickinson and Company; GlaxoSmithKline PLC; Phillips-Medisize Corporation; AptarGroup Inc.; Dexcom Inc.; West Pharmaceutical Services Inc.; Insulet Corporation; OPKO Health Inc.; Tandem Diabetes Care Inc.; Ypsomed AG; Meridian Medical Technologies LLC; Propeller Health; Findair Sp. z.o.o
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r27759u

1. Executive Summary

2. Connected Drug Delivery Devices Market Characteristics

3. Connected Drug Delivery Devices Market Trends And Strategies

4. Connected Drug Delivery Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Connected Drug Delivery Devices Growth Analysis And Strategic Analysis Framework

5.1. Global Connected Drug Delivery Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Connected Drug Delivery Devices Market Growth Rate Analysis
5.4. Global Connected Drug Delivery Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Connected Drug Delivery Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Connected Drug Delivery Devices Total Addressable Market (TAM)

6. Connected Drug Delivery Devices Market Segmentation

6.1. Global Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Standalone Components And Software
Integrated Devices
6.2. Global Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Bluetooth
Near-Field Communication (NFC)
Other Technologies
6.3. Global Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Parenteral
Inhalational
6.4. Global Connected Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Asthma
Chronic Obstructive Pulmonary Disease
Diabetes Management
Other Applications
6.5. Global Connected Drug Delivery Devices Market, Sub-Segmentation Of Standalone Components And Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Mobile Applications
Connectivity Modules
Data Analytics Software
6.6. Global Connected Drug Delivery Devices Market, Sub-Segmentation Of Integrated Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Smart Inhalers
Smart Auto-injectors
Connected Syringes
Wearable Drug Delivery Devices

7. Connected Drug Delivery Devices Market Regional And Country Analysis

7.1. Global Connected Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Connected Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Connected Drug Delivery Devices Market

8.1. Asia-Pacific Connected Drug Delivery Devices Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Connected Drug Delivery Devices Market

9.1. China Connected Drug Delivery Devices Market Overview
9.2. China Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Connected Drug Delivery Devices Market

10.1. India Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Connected Drug Delivery Devices Market

11.1. Japan Connected Drug Delivery Devices Market Overview
11.2. Japan Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Connected Drug Delivery Devices Market

12.1. Australia Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Connected Drug Delivery Devices Market

13.1. Indonesia Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Connected Drug Delivery Devices Market

14.1. South Korea Connected Drug Delivery Devices Market Overview
14.2. South Korea Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Connected Drug Delivery Devices Market

15.1. Western Europe Connected Drug Delivery Devices Market Overview
15.2. Western Europe Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Connected Drug Delivery Devices Market

16.1. UK Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Connected Drug Delivery Devices Market

17.1. Germany Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Connected Drug Delivery Devices Market

18.1. France Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Connected Drug Delivery Devices Market

19.1. Italy Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Connected Drug Delivery Devices Market

20.1. Spain Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Connected Drug Delivery Devices Market

21.1. Eastern Europe Connected Drug Delivery Devices Market Overview
21.2. Eastern Europe Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Connected Drug Delivery Devices Market

22.1. Russia Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Connected Drug Delivery Devices Market

23.1. North America Connected Drug Delivery Devices Market Overview
23.2. North America Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Connected Drug Delivery Devices Market

24.1. USA Connected Drug Delivery Devices Market Overview
24.2. USA Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Connected Drug Delivery Devices Market

25.1. Canada Connected Drug Delivery Devices Market Overview
25.2. Canada Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Connected Drug Delivery Devices Market

26.1. South America Connected Drug Delivery Devices Market Overview
26.2. South America Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Connected Drug Delivery Devices Market

27.1. Brazil Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Connected Drug Delivery Devices Market

28.1. Middle East Connected Drug Delivery Devices Market Overview
28.2. Middle East Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Connected Drug Delivery Devices Market

29.1. Africa Connected Drug Delivery Devices Market Overview
29.2. Africa Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Connected Drug Delivery Devices Market Competitive Landscape And Company Profiles

30.1. Connected Drug Delivery Devices Market Competitive Landscape
30.2. Connected Drug Delivery Devices Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

31. Connected Drug Delivery Devices Market Other Major And Innovative Companies

31.1. Novartis AG
31.2. Medtronic PLC
31.3. Eli Lilly and Company
31.4. Amgen Inc.
31.5. Boehringer Ingelheim International GmbH
31.6. Novo Nordisk A/S
31.7. Merck Group
31.8. Becton Dickinson and Company
31.9. GlaxoSmithKline PLC
31.10. Phillips-Medisize Corporation
31.11. AptarGroup Inc.
31.12. Dexcom Inc.
31.13. West Pharmaceutical Services Inc.
31.14. Insulet Corporation
31.15. OPKO Health Inc.

32. Global Connected Drug Delivery Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Connected Drug Delivery Devices Market

34. Recent Developments In The Connected Drug Delivery Devices Market

35. Connected Drug Delivery Devices Market High Potential Countries, Segments and Strategies

35.1 Connected Drug Delivery Devices Market In 2029 - Countries Offering Most New Opportunities
35.2 Connected Drug Delivery Devices Market In 2029 - Segments Offering Most New Opportunities
35.3 Connected Drug Delivery Devices Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer